Entera Bio shareholders elect Yonatan Malca and approve all proposals at 2022 annual meeting

Entera Bio Ltd.

Yonatan Malca elected to board for three-year term; 11,060,520 votes for, 47,457 against.
CEO Miranda Toledano's compensation ratified: 8,074,581 for, 2,959,002 against.
Amendment to 2018 equity plan increasing shares by 576,188 approved: 8,420,408 for.
Kesselman & Kesselman (PwC) ratified as auditor for FY2022 with 11,061,302 votes for.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.